An update from Holista Colltech Limited ( (AU:HCT) ) is now available.
Holista Colltech Limited has appointed Mr. Lai Kwok Kin as the new Independent, Non-Executive Chair of the Board. Mr. Lai, who has been an independent Non-Executive Director since March 2024, brings expertise in investor relations and corporate strategy. His appointment follows the resignations of the previous Chair, Mr. David Deloub, and Director, Ms. Loren King. This leadership change is seen as a strategic move to strengthen Holista’s governance and drive sustainable growth.
More about Holista Colltech Limited
Holista Colltech Ltd is a research-driven biotech company formed from the merger of Holista Biotech Sdn. Bhd. and Colltech Australia Ltd. The company is listed on the Australian Securities Exchange and is headquartered in Perth, with extensive operations in Malaysia. Holista focuses on developing natural solutions for healthier living, offering proprietary solutions for food manufacturers to create healthier products without chemicals. The company also specializes in advanced collagen and nano-collagen technologies.
YTD Price Performance: 320.0%
Average Trading Volume: 218,862
Technical Sentiment Signal: Sell
Current Market Cap: A$12M
For detailed information about HCT stock, go to TipRanks’ Stock Analysis page.